icone plus
Contact
Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Substantial
Substantial actual benefit
Clinical Added Value
no clinical added value
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection.
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
wB4RUsr5DNsRVnX4